Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rezolute, Inc. | 4,000,000 | reported | 31 Oct 2016 | tx 4+5,642,393 |
| Akari Therapeutics Plc | 3,093,293 | reported | 16 Dec 2025 | tx 9+10,502,473 |
| Eidos Therapeutics, Inc. | 83,750 | reported | 22 Jun 2018 | tx 1+83,720 |
| GERON CORP | 70,000 | reported | 15 May 2018 | tx 30+676,801−65,000 |
| PLIANT THERAPEUTICS, INC. | 30,000 | reported | 05 Jun 2025 | tx 7+1,238,910 |
| CytomX Therapeutics, Inc. | 14,000 | reported | 13 Jun 2018 | tx 3+56,000 |
| NEKTAR THERAPEUTICS | 5,000 | reported | 02 Dec 2008 | tx 9+430,750 |
| FACET BIOTECH CORP | 0 | reported | 21 Apr 2010 | tx 4+25,000−25,000 |
| Ignyte Acquisition Corp. | 0 | reported | 14 Nov 2024 | tx 39+15,322,869−16,414,968 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 3,093,293 | — | derivfirst after silence |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 3,093,293 | 0.40 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 618,658 | 0.40 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 618,658 | — | deriv |
| 05 Jun 2025 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 225,000 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 175,000 | 0.00 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 892,857 | 1.12 USD | |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 892,857 | 1.12 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 892,857 | 1.12 USD | deriv |
| 14 Nov 2024 | OTHER | Ignyte Acquisition Corp. | 4,574,661 | — | |
| 14 Nov 2024 | OTHER | Ignyte Acquisition Corp. | 372,940 | — | |
| 14 Nov 2024 | OTHER | Ignyte Acquisition Corp. | 8,382,742 | — | |
| 14 Nov 2024 | CONVERSION | Ignyte Acquisition Corp. | 4,574,661 | — | |
| 14 Nov 2024 | OTHER | Ignyte Acquisition Corp. | — | 0.00 USD | deriv |
| 14 Nov 2024 | CONVERSION | Ignyte Acquisition Corp. | 176,292 | — | deriv |
| 14 Nov 2024 | OTHER | Ignyte Acquisition Corp. | 1,200,000 | — | deriv |
| 13 Jun 2024 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 26,764 | 0.00 USD | deriv |
| 21 Sept 2023 | PURCHASE | Ignyte Acquisition Corp. | 45,000 | — | |
| 20 Sept 2023 | PURCHASE | Ignyte Acquisition Corp. | 30,000 | — | |
| 19 Sept 2023 | PURCHASE | Ignyte Acquisition Corp. | 50,000 | — | |
| 15 Sept 2023 | PURCHASE | Ignyte Acquisition Corp. | 25,000 | — | |
| 14 Sept 2023 | PURCHASE | Ignyte Acquisition Corp. | 20,000 | — | |
| 13 Sept 2023 | PURCHASE | Ignyte Acquisition Corp. | 30,000 | — | |
| 11 Sept 2023 | PURCHASE | Ignyte Acquisition Corp. | 30,000 | — |
1 purchase reported after at least 12 months of silence — most recent on 16 Dec 2025.